Worldwide spread of COVID-19 pandemic and risk factors among co-morbid conditions especially diabetes mellitus in India
Research Journal of Pharmacy and Technology
; 13(5):2530-2532, 2020.
Article
in English
| EMBASE | ID: covidwho-809338
ABSTRACT
This narrative review aims to know the association of the novel corona virus disease (COVID-19) in patients with diabetes mellitus and other co-morbidities. COVID 19 has reached the number 2.5 million of cases according to the situation report of World Health Organization on 21st, April 2020, affecting nearly 210 countries worldwide. It's highly virulent, involves ‘flu-like symptoms’, which are mild in most cases, in severe condition, results into acute respiratory distress syndrome, multiple organ failure leading to the blockage in lower respiratory tract/pathways and difficulty in breathing, it increases the risk for hospitalization and sometimes, leads to death in COVID-19 patients. Most of the patients are asymptomatic, but they can be a carrier to those who have less immunity. Patient with other co-morbidities like diabetes, cardiac problems, and older ages fails to survive as they are more prone to virus infections. The additional burden of disease can be one of the factors to the mortality in these cases.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Language:
English
Journal:
Research Journal of Pharmacy and Technology
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS